0 works0 citations0 h-index

Lars Rydén

Karolinska Institutet(SE)

Publications by Year

Research Areas

Diabetes Treatment and Management, Metabolism, Diabetes, and Cancer, Cardiovascular Function and Risk Factors, Hyperglycemia and glycemic control in critically ill and hospitalized patients, Diabetes, Cardiovascular Risks, and Lipoproteins

Most-Cited Works

→ Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial(2019)2,890 cited
→ ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD(2013)1,949 cited
→ Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): Effects on mortality at 1 year(1995)1,573 cited
→ Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity(2005)1,063 cited
→ EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries(2015)996 cited
→ European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)(2012)691 cited

→ ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society(2006)666 cited

→ Guidelines for the management of patients with atrial fibrillation. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to develop guidelines for the management of patients with atrial fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysiology(2001)493 cited

→ Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC-EORP EUROASPIRE V survey in 27 countries(2019)354 cited

→ Diabetes mellitus: the major risk factor in unstable coronary artery disease even after consideration of the extent of coronary artery disease and benefits of revascularization(2004)330 cited